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Abstract
Intracellular trafficking is critical for delivering molecules and organelles to their proper destinations to carry out normal
cellular functions. Disruption of intracellular trafficking has been implicated in the pathogenesis of various
neurodegenerative disorders. In addition, a number of genes involved in vesicle/organelle trafficking are also essential
for pigmentation, and loss of those genes is often associated with mouse coat-color dilution and human hypopigmentary
disorders. Hence, we postulated that screening for mouse mutants with both neurological defects and coat-color dilution
will help identify additional factors associated with intracellular trafficking in neuronal cells. In this study, we characterized a
mouse mutant with a unique N-ethyl-N-nitrosourea (ENU)–induced mutation, named nur17. nur17 mutant mice exhibit both
coat-color dilution and ataxia due to Purkinje cell degeneration in the cerebellum. By positional cloning, we identified that
the nur17 mouse carries a T-to-C missense mutation in archain 1 (Arcn1) gene which encodes the d subunit of the coat
protein I (COPI) complex required for intracellular trafficking. Consistent with this function, we found that intracellular
trafficking is disrupted in nur17 melanocytes. Moreover, the nur17 mutation leads to common characteristics of
neurodegenerative disorders such as abnormal protein accumulation, ER stress, and neurofibrillary tangles. Our study
documents for the first time the physiological consequences of the impairment of the ARCN1 function in the whole animal
and demonstrates a direct association between ARCN1 and neurodegeneration.
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Introduction
Intracellular trafficking is critical for delivering molecules and
organelles to their proper destinations to perform normal cellular
functions (reviewed in [1]). Proteins and lipids are transported to
the target cellular compartments through vesicular trafficking
pathways, and organelles are trafficked along microtubules and
actin cytoskeleton. Impairment of intracellular trafficking has been
implicated in the pathogenesis of various neurodegenerative
disorders, such as Alzheimer’s disease (reviewed in [2,3]),
Huntington disease [4–6] and Parkinson’s disease [7], indicating
the importance of intracellular trafficking for proper function and
maintenance of neuronal cells. However, factors that are involved
in this process and their associations with the mechanisms causing
neurodegeneration are not yet fully understood.
The molecular mechanisms of intracellular trafficking are
shared by different cell types and organ systems. This is evident
from the fact that multiple organ systems are affected in a number
of human diseases caused by defects in intracellular trafficking. For
example, Hermansky-Pudlak Syndrome (HPS), a collection of
heterogeneous genetic disorders caused by defects in intracellular
vesicle trafficking, is characterized by oculocutaneous albinism and
defective platelet storage [8], suggesting that the affected protein
trafficking pathways are shared between skin and blood cells.
Fundamental intracellular trafficking mechanisms are also shared
by the skin and nervous systems. For example, Griscelli syndrome
(GS) type 1 which is caused by mutations in the myosin 5a
(MYO5A) gene is characterized by pigmentary dilution of the skin
and hair and neurological defects with severe ataxic movement
[9]. The Myo5a mouse mutant, dilute, also exhibits coat color
dilution and severe ataxic movement [10]. Studies on dilute mice
demonstrated that MYO5A, an actin-based motor protein,
participates in organelle trafficking in both melanocytes and
neuronal cells [11–13]. Intracellular melanosome trafficking is
disrupted in melanocytes of dilute mice, leading to coat color
dilution [13]. Moreover, endoplasmic reticulum (ER) transport in
cerebellar Purkinje cells (PCs) is disrupted in dilute mutants, which
may result in neurological defects [11]. Mutations in Fig4 and
Vac14, affecting the conversion of phosphatidylinositol-3-phos-
phate (PI3P) to the signaling lipid phosphatidylinositol-3,5-bispho-
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pigmentation in mice [14,15]. Pl(3,5)P2 regulates vesicle trafficking
in the endosome-lysosome axis in yeast [16], and abnormalities
indicative of defects in the regulation of endosomal vesicles are
observed in these mutant mice [14,15]. Pigment containing hair
follicles are greatly reduced in the skin of Fig4 mutant mice,
suggesting that lysosome-melanosome biogenesis may be affected
[14]. Another mouse mutant with both pigmentary and neuro-
logical defects is the sandy mouse with a mutation in a component
of biogenesis of lysosome-related organelles complex 1 (BLOC-1),
which regulates trafficking to lysosome-related organelles including
melanosomes [17].
Based on the findings that the vesicle/organelle trafficking
pathways are shared among multiple organs, we postulated that
screening for mouse mutants exhibiting phenotypes indicative of
defects in intracellular trafficking in multiple tissues may yield
molecules important for this process. Among defects in different
organs, coat color dilution is a good indicator for defective
intracellular trafficking because the defect can be readily observed
in the whole animal. A number of mouse mutants that show coat
color dilution have been isolated and defective vesicle and
organelle trafficking pathways are the major causes of coat color
dilution in these mice [8,18]. For example, all the sixteen mouse
mutants with dilute coat color that were identified as models to
study HPS carry mutations in genes that are involved in vesicle
trafficking to melanosomes [8,19,20]. Mouse models of Griscelli
syndrome also exhibit dilute coat color and bear mutations in
components of the RAB27A-MLPH-MYO5A complex that are
necessary for proper intracellular trafficking of melanosomes
[10,21,22].
In this study, we screened for mice with both a neurological
defect (ataxia) and coat color dilution, and identified a novel
mutant, neurological 17 (nur17). We performed positional cloning
of the nur17 mutation and identified a single nucleotide
substitution in archain 1 (Arcn1), a highly conserved gene that
encodes the d subunit of the coat protein I (COPI) complex [23].
Further characterization of the coat color and neuronal pheno-
types indicated that the nur17 mutation perturbs intracellular
protein trafficking and ER function in the affected tissues. Our
study is the first demonstration of the physiological consequences
of the impairment of the ARCN1 function in mammalian tissues in
vivo, and provides a direct link between the ARCN1 functions and
neurodegeneration.
Results
Coat-color dilution and progressive Purkinje cell
degeneration in nur17 mice
The autosomal recessive nur17 mutation was generated by ENU
mutagenesis at Mouse Mutagenesis Center for Developmental
Defects at Baylor College of Medicine [24,25]. Initial phenotypic
characterization showed that nur17 mice exhibit both coat color
dilution (Figure 1A) and ataxic movements. The coat color
dilution phenotype of nur17 mice was noted to be milder compared
with that of dilute-lethal (Myo5a
d-l) mice [10], and to become more
notable with age. The ataxic phenotype, which is also milder in
nur17 mice than that of Myo5a
d-l mice, was observed around the
age of 2 months and developed progressively as the mice age. The
size of nur17 mice was smaller compared to unaffected control
littermates (+/+ or nur17/+) (Figure 1A and 1B) (control: n=5,
nur17 mice: n=7; p,0.01 by student’s t-test).
To further characterize the coat color dilution, we examined the
distribution of pigment in hair samples from nur17 and littermate
control (+/+, nur17/+) mice. In the hair of control mice, the
pigment was incorporated all the way to the tip in a regularly
repeated pattern (Figure 1C, top). In the hair of nur17 mice, we
observed increased spacing between pigment bands and an
occasional absence of pigment in the midshaft (Figure 1C,
bottom). The ratio of hairs with abnormal pigmentation at the
base, midshaft and tip was significantly higher in nur17 mice
compared to control mice (control: n=5, nur17 mice: n=5, 30
hairs from each mouse, Student’s t-test, Figure 1D). These hair
phenotypes suggest that the nur17 gene product is required for the
proper transport/incorporation of pigment into the hair.
nur17 mice also exhibit ataxic movements beginning around 2
months of age. Because the cerebellum is the center for motor
coordination, we examined the morphology of the cerebellum in
nur17 mice. Purkinje cells (PCs) were visualized using a PC marker,
anti-calbindin [26]. In littermate control (+/+, nur17/+) mice, PCs
were aligned in a single cell layer adjacent to each other
(Figure 1E). At 1 month of age before the appearance of ataxic
movements, nur17 mice showed normal cerebellar morphology
with an intact PC layer despite showing a few signs of
degeneration (Figure 1E). However, in 2-month-old nur17 mice,
we observed extensive loss of PCs compared to control mice
(Figure 1E, right panels). We also found a specific regional pattern
for PC degeneration in nur17 mice. By 2 months of age, most of
the PCs in a part of lobule VI and lobules VII to X of nur17 mice
have degenerated (Figure 1E). In contrast, PCs in lobules I to V
remained at this age (Figure 1E).
Positional cloning of the nur17 gene
We genetically mapped the nur17 gene on mouse chromosome
9 using an F2 intercross (nur17 6 AKR). All F1 animals (14
females and 13 males) were phenotypically normal and did not
show any coat color dilution or ataxic phenotypes. To map the
nur17 locus, we employed microsatellite markers and single-
nucleotide polymorphisms (SNPs) to distinguish between the
alleles of nur17 (mixed background of C57BL/6J, 129S6/
SvEvTac and 129S1/SvImJ) and AKR. For initial mapping, we
tested genomic DNA from F2 mice including 8 affected mice with
80 microsatellite markers across the whole genome. We observed
co-segregation of a marker D9Mit69 with the nur17 phenotypes
Author Summary
The fact that mutations in single gene can result in defects
in multiple organs suggests the existence of similar
fundamental cellular mechanisms shared by different
organs. Thus, genes that are important for a certain
cellular function in a tissue of interest can be identified by
searching for mutations that cause visible abnormalities
indicative of such defect in other tissues. Here, we
identified a gene essential for vesicle trafficking in
neuronal cells by screening for mouse axtaxia mutants
with diluted coat color, which often indicates defective
intracellular trafficking in skin cells. This mouse mutant,
neurological 17 (nur17), was generated by ENU mutagen-
esis. By positional cloning, we identified a mutation in the
archain 1 gene encoding a component of the COPI
complex, which is known to be involved in intracellular
protein trafficking. The mutation in archain 1 results in
phenotypes commonly observed in neurodegenerative
disorders such as abnormal protein accumulation, ER
stress, and neurofibrillary tangles. nur17 mice provide a
new model to study the association between intracellular
trafficking and the mechanisms of neurodegenerative
diseases.
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Additional F2 animals were tested to further narrow down the
nur17 locus. We collected a total of 822 meioses (411 F2 mice)
(Figure 2A). Of note, the coat color dilution and ataxic
phenotypes always co-segregated in this mapping cross, indicating
that a single gene mutation likely accounts for both phenotypes.
After progeny testing of F2 mice carrying critical recombination
(Figure 2B), the minimal genetic region of nur17 was determined
to be between D9SNP25 and D9Mit69 (Figure 2C). A total of 36
genes are localized within this 1.06 Mb interval. We selected 4
genes, dolichyl-phosphate N-acetylglucosamine phosphotransfer-
ase (Dpagt1), vacuolar protein sorting 11 (Vps11), trafficking
protein particle complex 4 (Trappc4) and archain 1 (Arcn1), as
candidates for nur17, since they are known to be associated with
vesicle trafficking. We sequenced the coding regions of these
candidate genes in nur17 mice and did not observe any nucleotide
change in Dpagt1, Vps11 and Trappc4. However, we identified a
single nucleotide change in the Arcn1 gene (Figure 2D). This T to
Cc o n v e r s i o ni nt h e1 0
th exon of the Arcn1 gene causes an amino
acid change from isoleucine (Ile) to threonine (Thr) at amino acid
422 (Figure 2D and 2E). The mutation is in the vicinity of the
cargo-binding site of ARCN1 which recognizes arginine-based
ER localization signals [27].
Transgenic expression of wild-type Arcn1 rescues nur17
phenotypes
To confirm that the Arcn1 mutation is responsible for the
phenotypes in nur17 mice, we tested whether transgenic (Tg)
expression of wild-type Arcn1 can rescue the nur17 phenotypes. We
generated a Tg construct (Figure 3A), in which expression of the
Arcn1 cDNA is driven by the chicken b-actin promoter and is
followed by the rabbit b-globin poly-A sequence (Figure 3A) [28].
We obtained 2 founder mice (2361 and 2368) that carried the
transgene and named the mice generated from these 2 founder
mice as line 2361 and line 2368 (Figure S1A). Phenotypes of nur17
mice were rescued in line 2361, in which expression of the
transgene was confirmed (Figure 3B–3D, Figure S1B). The coat
color dilution and lower body weight in nur17 mice were
completely rescued in mice expressing the wild-type Arcn1
transgene (Figure 3B and 3C). We also analyzed the ataxic
phenotype using rotarod (Figure 3D). While this analysis revealed
significantly decreased latency in nur17 mice compared to control
mice (p=0.0046 by student’s t-test), this phenotype was rescued by
the expression of the Arcn1 transgene (Figure 3D). In addition, we
examined the PC degeneration phenotype in 2 month-old mice
and observed no PC degeneration in nur17 mice carrying the
transgene (Figure 3D, right). We tested a total of 7 nur17/
Figure 1. Coat color dilution and Purkinje cell degeneration in nur17 mice. (A) Diluted coat color in nur17 mice (right) compared with
control mice (left). (B) Body weight of 2-month old nur17 (n=7, female) and control (n=5, female) mice. Error bars represent standard error. **p,0.01
(C) Pigment distribution in the hair of control and nur17 mice. Base, midshaft and tips of the hair of control (top) and nur17 (bottom) mice are shown.
Representative pictures from 30 hairs of each genotype are shown. (D) Ratio of hairs with abnormal pigmentation in the base (left), midshaft (center)
and tip (right). Total of 150 hairs from 5 nur17 and 5 control mice (30 hairs each) were examined. Error bar represent standard error. *p,0.05;
**p,0.01 (E) Degenerative loss of the Purkinje cells in nur17 mice. Purkinje cells are labeled with anti-calbindin (green) and nuclei are stained with
DAPI (blue). Note that by 2 months of age, nur17 mice lose their Purkinje cells in Lobule IX. Upper scale bar: 1mm; Bottom scale bar: 0.1mm.
doi:10.1371/journal.pgen.1000956.g001
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mice. In line 2368, the phenotypes of nur17 mice were not rescued
(data not shown). However, we found that the transgene is not
expressed in this line (Figure S1B). These results demonstrated that
the single nucleotide change in Arcn1 is the causal mutation in
nur17 mice.
Expression and cellular localization of ARCN1
ARCN1, also known as d-COP, is a subunit of the coat protein
I (COPI) complex [29]. The COPI complex was first isolated
from mammalian sources as a cytosolic protein complex and
components of Golgi derived vesicles [30,31]. It was originally
found to be involved in retrograde trafficking from the cis-Golgi
to the rough ER (reviewed in [32]) and in intra-Golgi trafficking
(reviewed in [33,34]) mostly based on studies in yeast. Studies
using mammalian cells with a mutation or depletion of a COPI
subunit have shown that COPI is essential for compartmental-
ization of secretory compartments, proper Golgi structure, ER-
Golgi transport and endosome functions [35–38]. Although the
phenotypes of a mutant for the yeast homolog of ARCN1
suggests its involvement in both retro and antero-grade ER-Golgi
trafficking [39], the role of this particular COPI subunit (d-COP)
in mammalian cells and the physiological consequences of its
impairment in the whole animal have not been examined. In
order to understand the function of ARCN1 in mammalian cells,
we first examined sub-cellular localization of ARCN1 using anti-
ARCN1 antibody (green) in primary cultured mouse melanocytes
(Figure 4). ARCN1 was co-localized with Golgi (Figure 4Ai) and
ER (Figure 4Aii) markers (red) and showed a punctate staining
pattern in the cytoplasm suggesting its localization in the vesicular
compartment (Figure 4Ai and Aii). In mouse melanocytes,
ARCN1 was co-localized with b-COP (red, Figure 4Aiii), which
is a known binding partner of ARCN1 in yeast [29], mainly in
ER and Golgi. This result indicated that ARCN1 (d-COP) is
present in a complex with b-COP in mammalian cells. We also
noted that there are vesicles positive for only ARCN1 (green,
arrowheads) and not b-COP (red) (Figure 4Aiii). This observation
was confirmed by co-expressing GFP-tagged ARCN1 and V5-
tagged b-COP (COPB1) in Neuro-2a cells (Figure 4B). The
ARCN1 signal does not always co-localize with b-COP signal.
These results indicate that ARCN1 may also exist unbound to b-
COP in mammalian cells, suggesting the possibility that ARCN1
may also have a function independent of b-COP or the COPI
complex. Further biochemical studies are required to test these
possibilities.
ARCN1 is involved in ER–Golgi and/or intra-Golgi
trafficking in melanocytes
In order to examine protein trafficking through ER and Golgi in
nur17 cells, we performed pulse-chase analysis in nur17 melano-
cytes using the melanosomal membrane protein Tyrp1 as an
indicator for intracellular trafficking [40,41]. We monitored ER-
Golgi transport using endoglycosidase H (endo H), which cleaves
N-linked sugar chain moieties on newly synthesized proteins that
are localized in the ER or intermediate compartments but not
those that have been modified in the Golgi. Without endo H
treatment [endo H (2)], newly synthesized Tyrp1 molecules that
have been glycosylated during biosynthetic transport through ER
and Golgi are represented by bands with higher molecular weight
compared to the band in the endo H (2) lane at 0 min. With endo
H treatment [endo H(+)], sugar chains on Tyrp1 molecules that
have been processed in Golgi and thus become resistant to endo H
digestion are represented by bands with higher molecular weight
compared to the band in the endo H (+) lane at 0 min. In control
melanocytes (from +/+, nur17/+ littermates), after 35 minutes of
chase, higher molecular weight bands were observed with endo H
and without endo H (black arrowheads in Figure 5A), suggesting
that some of the Tyrp1 molecules have been trafficked into Golgi
Figure 2. Positional cloning of the nur17 gene. (A) The haplotypes for 822 chromosomes from 411 F2 mice are indicated. (B) Genotypes and
phenotypes of two recombinant mice that were critical for determining the minimal region for the nur17 locus. (C) Minimal genetic region of the
nur17 locus. (D) Point mutation in the Arcn1 gene from nur17 mice. T to C nucleotide transition causes an amino-acid change from Ile to Thr at amino
acid (aa) 422. (E) Point mutation is located in the 10
th exon of the Arcn1 gene in nur17 mice.
doi:10.1371/journal.pgen.1000956.g002
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contrast, little or no higher molecular weight bands were observed
in the nur17 melanocytes at this timepoint (red arrowheads in
Figure 5A). At 45 min, the bulk of Tyrp1 protein was shifted to a
higher molecular weight form in control melanocytes, whereas a
band of lower molecular weight still remained in nur17
melanocytes (white arrowheads). We quantified this shift by
measuring the intensity of radioactive signals in these bands as
shown in Figure 5B. The proportion of protein without complex
N-linked glycans (lower band) was significantly higher in
melanocytes of nur17 mice compared to cells from control mice
(P,0.0001, 2 way ANOVA). These results suggest that the
efficiency of protein trafficking through ER and Golgi may be
affected in nur17 mice. Alternatively, it is possible that these results
indicate pertubation of the glycosylation process in the Golgi of
nur17 mice. If retrograde transport of oligosaccharide transferases
within the Golgi apparatus is defective due to the mutation,
deprivation of these enzymes in appropriate Golgi cisternae could
occur, causing delay in glycosylation. This scenario would be
consistent with the proposed function of COPI in intra-Golgi
retrograde transport of resident proteins in the cisternal matura-
tion model of protein transport through Golgi [34].
Figure 3. Phenotypes of nur17 mice are rescued by wild-type Arcn1. (A) Transgenic construct for generating the transgenic mice expressing
Arcn1 gene. Restriction enzyme (PstI) sites to digest DNA for southern blotting were labeled. The black bar represents the region used for the probe
for southern blot. (B) Rescue of smaller body weight by transgene in nur17 mice. Smaller size in nur17 mice (middle, n=13, female) is rescued by the
introduction of transgene, Arcn1 (right, n=6, female) (p=0.003). There is no significant difference between the weight of rescued mice (right) and the
control mice (left, n=7, female) (p=0.44). (C) Rescue of coat color dilution. Coat color dilution phenotype in nur17 mice (middle) is rescued by the
introduction of transgene, Arcn1 (right). (D) Rescue of the motor coordination defect. Latency to fall on the accelerating rotatod was recorded for
control mice (n=5), nur17 mice (n=5) and nur17 mice with the Arcn1 transgene (n=5). The rotarod performance was significantly improved by the
transgene (p=0.015), and was comparable to that in control mice (p=0.613). (E) Rescue of Purkinje cell degeneration. Purkinje Cell degeneration
phenotype in 2-month old nur17 mice (middle) is completely rescued by the introduction of transgene, Arcn1 (right). Purkinje cells are labeled with
anti-calbindin (green) and nuclei are stained with DAPI (blue). Scale bar: 1mm.
doi:10.1371/journal.pgen.1000956.g003
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mice
Based on the possible trafficking defects observed in melano-
cytes of nur17 mice, we hypothesized that such intracellular
trafficking mechanism is also impaired by the nur17 mutation in
the PC. Electron microscopic analysis of the cerebellum of nur17
mice showed abnormal accumulation of proteins in the dendrites
of PCs (red arrow, Figure 6A) as well as in perinuclear areas (red
arrow, Figure 6B, PC nucleus is marked by red star) [42]. Since
accumulation of misfolded protein has been associated with defects
in vesicle trafficking followed by ER stress [7], we then examined
whether ER stress occurs in the degenerating PCs of nur17 mice
using an ER stress marker, anti-CCAAT/enhancer-binding
protein homologous protein (CHOP) [42]. We observed high
levels of CHOP signals in the cell bodies of some PCs in nur17
mice (Figure 6D, white arrowhead), while we never observed
CHOP signals in PCs of littermate control (+/+, nur17/+) mice
(Figure 6C). The mean ratio of CHOP positive PCs against total
PCs was statistically higher in nur17 mice (0.84%; n=4) compared
to control mice (0%; n=3) (p=0.016 by student’s t-test). The fact
that not all PCs were positive for CHOP staining is consistent with
the idea that PC degeneration does not occur simultaneously in all
PCs but rather occurs progressively. We also performed
immunohistochemistry with an anti-KDEL antibody, which
recognizes the ER stress markers, BiP/Grp78 and Grp94.
Although KDEL signals were detected in PCs of both control
and nur17 mice, no difference was observed between them
(Figure S2).
Neurofibrillary tangles in the cerebellum of nur17 mice
Through electron microscopic analysis, we also observed
abnormal filamentous lesions in the cerebellum of all 30-day-old
nur17 mice examined (n=3) (Figure 7A), but not in the littermate
control (+/+, nur17/+) (n=3) mice. We examined the distribution
of abnormal accumulation of filaments by Gallyas staining, which
is known to stain protein aggregates of neurofilaments [43].
Central sagittal sections of the cerebellum from 4 control and 5
nur17 mice at 4 weeks of age were subjected to Gallyas staining
(Figure 7B–7D), and the number of positively-stained cells was
counted. While we observed no positively-stained cells in control
mice (n=4), an average of 83628.8 PCs in the central sagittal
section of cerebellum were positively stained in nur17 mice (n=5,
p,0.05, Student’s t-test). High magnification images (Figure 7D)
showed that staining is localized to the PC body and dendrites.
Figure 4. Subcellular localization of ARCN1. (A) Primary culture of wild-type mouse melanocytes are labeled with anti-ARCN1 (green) indicating
the localization of ARCN1 and anti-Golgi protein (red) (i); anti-KDEL (red) (ii) and anti-bCOP (red) (iii). (B) Neuro-2a cells transfected with constructs for
GFP-tagged ARCN1 (green) and V5-tagged bCOP (red). Nuclei are stained with DAPI (blue). Merged pictures are shown and high magnification
pictures are shown in the right panel. Scale bar for low magnification: 10mm. Scale bar for high magnification: 5mm.
doi:10.1371/journal.pgen.1000956.g004
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component of NFTs in Alzheimer’s disease, we did not observe
signals when immunohistochemistry was performed on the
cerebellum of nur17 mice using anti-hyperphosphorylated tau
antibodies (data not shown), indicating that NFTs in nur17 mice
may not contain hyperphosphorylated tau. It has been suggested
that hyperphosphorylation of tau is not obligatory in the formation
of neurofibrillary tangles [44], which may be the case in this
mutant.
Discussion
Here we show that a mutation in Arcn1 is responsible for the
phenotypes in an ENU-induced mouse mutant, nur17, which was
identified by screening for mice with both diluted coat color and
ataxia. We identified a missense mutation in Arcn1 in nur17 mice
and confirmed that it is responsible for coat color dilution and PC
degeneration by transgenic rescue. ARCN1, also known as d-
COP, is a sub-unit of the coat protein I (COPI) complex, which
comprises one of the protein coats that mediate vesicle budding
from the membrane (reviewed in [32,45–47]). Thus, nur17 mice
provide a unique model to study the intracellular trafficking and its
association with neuronal function and pigmentation in mammals.
Our results suggest that the single nucleotide substitution
causing an amino acid change from isoleucine to threonine results
in abnormal function of the ARCN1 protein. Since the mode of
inheritance for the nur17 mutation is recessive, the mutation was
expected to cause loss of the protein function rather than gain of
function. Our transgenic rescue experiment showed that the wild-
type allele of Arcn1 completely rescues the phenotypes of nur17
Figure 5. Kinetic analysis of biosynthesis and transport of Tyrp1 in the melanocyte. (A) Pulse chase analysis of control and nur17
melanocytes. Control and nur17 melanocytes were pulse labeled for 10 min with [
35S] methionine followed by a chase as the indicated times. The size
of Tryp1 is monitored after pulse labeling with [
35S] and analyzed by 9% SDS-PAGE. (Molecular weight markers are shown on the left.) (B)
Quantification of the proportion of Tyrp1 without complex N-linked glycans at 5 different chasing time points (0min, 15min, 25min, 35min and
45min). Error bar represents standard error.
doi:10.1371/journal.pgen.1000956.g005
Figure 6. Abnormal protein aggregation and upregulated ER
stress marker in the cerebellum of nur17 mice. (A) Ultrastructural
analysis showed protein inclusion (red arrow) in the dendrite of PC. (B)
Protein inclusion (red arrow) also exists in the perinuclear region of PC.
PC nucleus is marked by a red star. (C, D) PC labeled with anti-Calbindin
(red) is negative for anti-CHOP antibody staining (green) in control mice
(C) but positive in nur17 mice (D, white arrowhead). Scale bar: 30um.
doi:10.1371/journal.pgen.1000956.g006
Archain 1 Mutation Causes Neurodegeneration
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nur17 causes partial rather than complete loss of ARCN1 function
based on the following reasons. First, Arcn1 encodes a protein
that is highly conserved from yeast to human, and mutations of
Arcn1 (d-COP) orthologs in other species such as yeast [29],
Drosophila (http://flybase.org, Flybase ID: FBal0096846) and C.
elegans (http://www.wormbase.org/db, Wormbase RNAi ID:
WBRNAi00033328 and WBRNAi00076118, [48]) all result in
lethality, suggesting that this molecule is fundamental to cellular
integrity and function. Secondly, mutants of other subunits of the
COPI complex in Drosophila and zebrafish also result in early
embryonic lethality [49,50]. Compared to the phenotypes in other
organisms, the phenotypes of nur17 mice are rather mild,
supporting the possibility that the nur17 mutation causes partial
loss of ARCN1 function. Thirdly, the mutation does not cause
RNA instability or improper processing of the protein, which
could cause complete loss of function, as the expression and
localization of ARCN1 are not altered in the nur17 melanocytes
(Figure S3). Alternatively, it is possible that other molecules with
similar functions compensate for the loss of ARCN1 function to
some extent. However, there are no obvious or known molecules
that could play such a role. Thus, it is likely that this missense
mutation uncovers roles for COPI that would not be discovered in
a complete loss of function allele.
The COPI complex was originally found to be involved in
retrograde vesicle trafficking from the cis-Golgi to the rough ER
(reviewed in [32]). However, studies in yeast suggested that d-
COP may be involved in both anterograde and retrograde ER-
Golgi trafficking [39]. Other studies also suggested expanded
roles of COPI complex in anterograde ER-Golgi trafficking and
trafficking between other compartments such as early endosomes
and the secretory pathway [35,38,51]. Consistent with these
findings, our results support the possibility that d-COP has
multiple roles in vesicle trafficking. First, the in vitro pulse-chase
assay indicated that the nur17 mutation causes either delays in
anterograde ER-Golgi protein trafficking or defects in intra-Golgi
retrograde transport of resident proteins, suggesting the involve-
ment of d-COP in these processes in mammalian cells. Secondly,
the localization study showed that ARCN1 is not only localized in
ER-Golgi, but also distributed in the cytosolic space, which may
represent localization of ARCN1 to other vesicular structures
such as endosomes or lysosomes. Further analysis of nur17 mice
should reveal whether ARCN1 functions in these organelles and
whether the mutation affects their functions. Our pulse-chase
study suggested a potential link between the Arcn1 mutation and
coat color dilution. Tyrp1 is a tyrosinase related protein (TRP)
and has been implicated in the biogenesis of melanosomes
[52,53]. The retardation of ER-Golgi transport of Tyrp1 from
ER to Golgi in nur17 melanocytes or impaired glycosylation of
this protein could potentially delay or inhibit melanosome
biogenesis resulting in coat color dilution. It is also possible that
ER-Golgi trafficking of other proteins required for melanosome
synthesis is affected as well. However, impaired ER-Golgi and/or
intra-Golgi trafficking may not be the only cause of coat color
dilution. As discussed above, the potential site of action of
ARCN1 is not restricted to ER-Golgi. Since biogenesis of
melanosomes includes multiple aspects of vesicle regulation such
as endocytosis and recycling of vesicles (reviewed in [54]), these
processes could be also affected in nur17 melanocytes. Further
analysis is needed to test these possibilities.
Defects in ER-Golgi or intra-Golgi trafficking similar to those
observed in melanocytes of nur17 mice could also be responsible
for PC degeneration in the cerebellum. For example, defective
ER-Golgi trafficking could be the direct cause of the formation of
Figure 7. Neurofibrilary tangles in the cerebellum of nur17 mice. (A, B) Ultrastructural analysis showed abnormal filamentous lesions (red
arrowhead) in the cerebellum of nur17 mice (A), while such lesions are not observed in control mice (B). The inset in (A) shows the higher
magnification of filamentous lesion. (C–E) Gallyas staining for control (C) and nur17 mice (D, E). Arrow denotes the PC that is positive for Gallyas
staining. Scale bar for (C, D): 1mm. Scale bar for (E): 0.1mm.
doi:10.1371/journal.pgen.1000956.g007
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result in ER-stress. On the other hand, ER-Golgi trafficking is
required for the unfolded protein response (UPR), which is
activated by ER-stress [55]. UPR helps to restore the normal ER
function by halting protein synthesis and upregulating molecular
chaperones involved in protein folding and ER associated
degradation (ERAD) to clear the protein accumulation (reviewed
in [56]). Therefore, defective ER-Golgi trafficking could be the
indirect cause of abnormal protein accumulation as well. Our
findings that abnormal protein accumulation and CHOP
expression, which is a sign of ER stress, are observed in nur17
mice support both hypotheses. Since ER-stress is known to trigger
signal transduction events that could induce cell death (reviewed in
[57]), it may cause degeneration of PCs in nur17 mice. However,
we did not observe upregulation of another ER stress marker,
KDEL, which is the protein sequence found in both BiP/Grp78
and Grp94. This result may indicate that abnormalities in nur17
PCs do not affect the typical ER stress pathway. Alternatively, we
may not be able to detect the increase in these proteins, because
only small numbers of PCs may be experiencing it at a time, which
would be consistent with the low number of CHOP-positive cells
we observed in nur17 mice. Nevertheless, our results provide
evidence that the defect in the COPI complex leads to
neurodegeneration, and suggest that ER abnormalities may be
involved in the neurodegenerative mechanism. Recent discovery
of Scy1-like1 (Scyl1) as a gene responsible for motor neuron and
PC degeneration in mice also suggests a link between the COPI
pathway and neurodegeneration [58,59]. SCYL1 binds to and co-
localizes with b-COP and regulates COPI-mediated retrograde
ER-Golgi trafficking [59]. Together with our results, these findings
support the notion that compromised COPI-mediated vesicle
trafficking causes neurodegeneration.
In addition to abnormal protein accumulation and possible
signs of ER-stress, nur17 mice show neurofibrillary tangles (NFT)
in the cerebellum that are commonly observed in a number of
neurodegenerative disorders such as Alzheimer’s Disease, Amyo-
trophic lateral sclerosis and Down’s Syndrome (reviewed in [60]).
Although ER stress and NFT are often observed together in many
human neurodegenerative diseases [61–63], the relationship
between these conditions is largely unknown. Our findings that
a mutation in a component of the COPI complex, which regulates
ER-Golgi vesicle trafficking, results in formation of NFT suggests a
possible new mechanism underlying NFT formation. Impaired
ER-Golgi vesicle trafficking could be the cause for NFT formation
in this model. Further analysis of nur17 mice should advance our
understanding of the molecular mechanism causing the formation
of NFT, which may be shared by a variety of neurodegenerative
disorders.
Provided that the Arcn1 gene is likely expressed ubiquitously in
all cell types, it is intriguing that gross abnormalities have been
detected only in the skin/hair and the cerebellum. It is possible
that there is another protein that can compensate for the loss of
ARCN1 in other cell types and tissues, although such protein has
not been biochemically discovered to date. Alternatively, the
affected tissues and cell types may be extraordinarily susceptible to
minor changes in efficiency of COPI function. A mutation in
another ubiquitously expressed protein known to function in ER-
Golgi and intra-Golgi trafficking, TRAPPC6A, also leads to a
tissue-restricted phenotype, pigment dilution, in mice [64]. Skin
cells may be particularly sensitive to defects in these trafficking
mechanisms. On the other hand, skin may be a unique tissue
where subtle defects in intracellular trafficking can be visibly
identified without the integrity of the skin being grossly affected,
making it a great in vivo model system to investigate the
mechanisms of intracellular trafficking.
Materials and Methods
Animals
All experiments were performed in accordance with the
National Institute of Health Guide for the Care and Use of
Laboratory Animals and were approved by the Animal Care and
Use Committee at the University of Wisconsin-Madison.
At Baylor College of Medicine, ENU mutagenesis was
performed using C57BL/6J males [25]. nur17 mice were isolated,
crossed to 129S6/SvEvTac three times and maintained in a mixed
background of C57BL/6J and 129S6/SvEvTac.
After importing nur17 mice to the University of Wisconsin-
Madison, we maintained the nur17 mutant allele and obtained the
affected animals for characterization by repeating this mating
scheme: nur17/nur17 founder females were mated with wild-type
129S1/SvImJ mice. nur17/+ F1 mice were intercrossed to obtain
affected nur17/nur17 mice. nur17/nur17 female mice were again
mated with 129S1/SvImJ.nur17/+ or +/+ littermate mice were
used as control mice in the experiments.
129S1/SvImJ and AKR/J mice were obtained from The
Jackson Laboratory.
Both 129S6/SvEvTac and 129S1/SvImJ strains are homozy-
gous for the A
w allele and display white-bellied agouti coat color.
All nur17 and control mice that were phenotyped in this study also
displayed agouti coat color.
We replaced the EGFP sequence in the pCX-EGFP vector
(kindly provided by Dr. Junichi Miyazaki; [65]) with the full length
Arcn1 cDNA and named it pCX-Arcn1. We used pCX-Arcn1 for
the transgene construct for the rescue experiment after lineariza-
tion with BamHI and SalI (New England Biolabs). The construct
was micro-injected into pronuclei of FVB/NJ embryos to generate
transgenic mice by the transgenic animal facility of the
Biotechnology Center at the University of Wisconsin-Madison.
We obtained two transgene-positive founders (2361 and 2368) and
crossed them to nur17 mice, and then intercrossed to obtain Tg-
positive nur17/nur17 mice.
Southern blotting genotyping procedures
We identified Transgene (Tg)-positive clones by Southern-blot
hybridization using PstI (New England Biolabs) digestion and
probes specific to Arcn1. The southern blot differentiated the
endogenous Arcn1 and the transgene based on size of bands
(1.05kb and 0.45kb for the transgene).
Tail DNA was prepared as described in [66]. ,15mg of DNA
was digested with the restriction enzyme PstI (New England
Biolabs) and resolved by 0.8% agarose gel electrophoresis. DNA
was transferred to Hybond N membrane (Amersham, GE
Healthcare) using alkaline capillary transfer, crosslinked with UV
(Spectroline). The membrane was prehybridized with prehybridi-
zation buffer (4xSSC, 1% milk powder, 1% SDS, 106Denharts
Reagent) and hybridized with probes labeled with [P32] dCTP
(Perkin Elmer) by Rediprime II Random Prime Labeling System
(Amersham, GE Healthcare) at 65uC using hybridization buffer
[4xSSC, 1% milk powder, 1% SDS and 37mg/ml salmon sperm
DNA (Sigma)]. The probe used for hybridization was PCR
amplified from mouse brain cDNA using primers, mArcn1-F3 (59
AAGCACCAGGATTTGGCGG 39) and mArcn1-R16 (59 TTA-
CAGGATTTCGTATTTGTC 39). Membranes were washed
three times with wash buffer I (2xSSC and 0.1% SDS) and twice
with wash buffer II (0.5xSSC and 0.1% SDS) for 15 min at 65uC
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detect the hybridization signal.
Northern blotting
The expression of the transgene was tested by a northern blot
that differentiates the endogenously expressed Arcn1 (4.4kb) and
expressed transgene (2.2kb). Total RNA was extracted from mouse
brains by Trizol (Invitrogen). mRNA was purified from total RNA
by Oligotex mRNA Midi Kit (Qiagen). mRNA was resolved by
formaldehyde agarose electrophoresis and transferred to Hybond
N membrane (Amersham, GE Healthcare) using alkaline capillary
transfer, crosslinked with UV (Spectroline). The membrane was
prehybridized with Rapid-Hyb Buffer (Amersham) with 37mg/ml
salmon sperm DNA (Sigma) and hybridized with probes labeled
with [P32] dCTP (Perkin Elmer) by Rediprime II Random Prime
Labeling System (Amersham, GE Healthcare) at 65uC using
Rapid-Hyb Buffer (Amersham) with 37mg/ml salmon sperm DNA
(Sigma). The probe used was the same described above for the
Southern-blot; similarly, the membranes were washed and
hybridization signal was detected as described above.
Genetic mapping
To map the nur17 gene, we performed a whole genome scan
using F2 animals from mating (nur176AKR/J) F1 mice. We
initially used 80 microsatellite markers, which distinguish AKR
alleles from both 129S1/SvImJTac and C57BL/6J alleles across
the whole genome. All F2 animals were phenotyped by both coat
color dilution and ataxia movement. Once the chromosomal
locus on chromosome 9 was identified for the nur17 mutation,
additional F2 mice were collected and additional markers were
used to further narrow the genetic region. We used two SNPs,
D9SNP3 (SNP ID on NCBI: NES11330700) and D9SNP25 (SNP
ID on NCBI: NES11338581), to differentiate AKR and nur17
alleles.
Genotyping
All genotyping was carried out by polymerase chain reaction
(PCR). For nur17 genotyping, PCR primers, mArcn1-F18 (59
CCTCAAACTCAGAAATCCGC 39) and mArcn1-R19 (59
TTGGCATCAATCACTGGC 39), were used for amplification
of the wild type (WT) allele and nur17 allele (470bp). BsrI (New
England Biolabs) was used to digest the nur17 allele specifically to
generate two bands (392bp and 78bp).
Immunohistochemistry
Littermate control (+/+, nur17/+) and nur17 mice were deeply
anesthetized with a mixture of ketamine and xylazine and perfused
with 4% paraformaldehyde (PFA). The heads were immersed in
4% PFA overnight at 4uC, and the brain was dissected out. For
paraffin sections, the brain was dehydrated in a graded ethanol
series, cleared in xylene, and embedded in paraffin. Sections were
cut at 6 mm, mounted on slides pretreated with Vectabond (Vector
Laboratories). For cryostat sections, the brain was cryoprotected at
4uC in a series of sucrose gradients after dissection. Brains were
embedded in optimal cutting temperature compound (OCT)
(Sakura Finetek) and sectioned at 12mm thickness.
For immunohistochemistry, sections were blocked with 2%
donkey serum and were incubated overnight with the primary
antibody against Calbindin-D (Swant), Calbindin (Abcam),
phosphorylated tau (abcam), hyperphosphorylated tau (Thermo
Scientific) and CHOP (Santa Cruz Biotechnology). Sections were
rinsed in PBS, and incubated with a 1:200 diluted Alexa 488
conjugated secondary antibody (Invitrogen) and/or Cy3 conju-
gated secondary antibody (Jackson Immunoresearch) for 45
minutes at room temperature. All sections were imaged on an
Eclipse E600 microscope (Nikon) using a SPOT camera (Spot
Diagnostics).
Electron microscopy
Littermate control (+/+, nur17/+) and nur17 mice were
anesthetized with ketamine/xylazine and perfused with 2% PFA
and 2.5% glutaraldehyde in 0.1M phosphate buffer for 11 min.
Cerebella were removed from the head and immersion fixed for
30 min. Then, cerebella were sectioned sagittally at 100mm
intervals with a Vibratome. Sections of the cerebella were
osmicated (1% osmium tetroxide) for 1 hr and washed in 0.1M
phosphate buffer, dehydrated through an ascending series of
ethanol and propylene oxide and embedded in Epon [25g Epon
812, 13g Dodecenyl Succinic Anhydride (DDSA), 12g Nadic
Methyl Anhydride (NMA) and 1ml 2,4,6-tris(dimethylamino-
methyl)phenol (DMP-30), Electron Microscopy Sciences]. Ultra-
thin sections (70nm) were cut and stained with uranyl acetate and
lead citrate. Sections were imaged on a Philips CM120 Scanning
Transmission Electron Microscope.
Gallyas-silver staining
The Gallyas-silver staining of the littermate control (+/+,
nur17/+) and nur17 cerebellum was performed as described in [67]
in order to examine the existence of neurofibrillary tangles.
Melanocyte culture
Mouse melanocytes were isolated from the skin on the back of
the Day2 littermate control (+/+, nur17/+) and nur17 mice and
cultured. Fresh skin specimens were incubated in foreskin media
(Dulbecco’s modified minimal essential medium (DMEM) (Gibco)
supplemented with 2% fetal bovine serum (Sigma-Aldrich),
penicillin (100 units/ml, Sigma) and gentamicin (100 ug/ml)
(Gibco) at 4uC overnight. The next day, the skin was washed three
times with Hanks’ balanced salt solution and excess fat was
removed. The samples were cut into small pieces and incubated in
0.25% trypsin solution (Hyclone) supplemented with 3.86 mg/ml
trypsin, from porcine pancreas (Sigma-Aldrich) at 4uC overnight.
Epidermis was separated from the dermis and epidermal cells were
suspended and cultured in Ham’s F10 nutrient medium
supplemented with 10% fetal bovine serum, 85 nmol/L 12-O-
tetradecanoylphorbol-13-acetate (TPA) (Sigma-Aldrich), 0.1 mmol/L
3-isobutyl-1-methylxanthine (IBMX) (Sigma-Aldrich), 2.5 nmol/L
cholera toxin (CT) (ICN Biochemicals) and penicillin (100 units/ml)
(Gibco).
Expression constructs and transfection of Neuro-2a cells
Ultimate ORF Human Clones for ARCN1 and coatomer
protein complex, subunit beta 1 (COPB1 or beta-COP) in
Gateway entry vector (Invitrogen; ARCN1: IOH43520, COPB:
IOH27122) were purified using a QIAprep Spin Miniprep Kit
(Qiagen) after culturing on the LB agar plate containing 10mg/
mL of kanamycin and in the LB liquid medium. pcDNA-
DEST53 (GFP-attR1-Cm
R-ccdB-attR2; Invitrogen) was used as
the destination vector for ARCN1, and pcDNA
TM/V5-DEST
(attR1-ccdB-Cm
R-attR2-V5 epitope; Invitrogen) was used as the
destination vector for COPB1. The LR recombination reaction
between the entry clone and a destination vector was carried out
using LR Clonase Enzyme (Invitrogen) according to the
protocols recommended in the product manual. The expression
constructs were then purified using a QIAfilter Plasmid Midi Kit
(Qiagen).
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high glucose (Gibco), supplemented with 10% FBS (Sigma). The
ARCN1 and COP1B expression constructs were transfected into
Neuro2A cells using SuperFect Transfection Reagent (Qiagen)
following the manufacture’s protocol and cultured for 24 hrs.
Immunocytochemistry
Cells were cultured on coverslips and were fixed by 4% PFA
for 10 min at 4uC. Cells were permeabilized using 0.5% Triton-
X in PBS for 30 min followed by blocking in 2% normal donkey
serum for 30 min. Then the cells were incubated with 1:200
diluted primary antibody against ARCN1 (Novus Biologicals),
58K Golgi protein (58K-9) (Abcam), KDEL (Abcam), b-COP
(Sigma), GFP (Synaptic System) and V5 (Invitrogen) in PBS with
0.1% Triton-X for 1 hour at room temperature. Cells were
washed in PBS and then incubated with 1:200 diluted Alexa 488
conjugated secondary antibody (Invitrogen) and Cy3 conjugated
secondary antibody (Jackson Immunoresearch) for 45 min at
room temperature. All immunocytochemistry slides were imaged
on a Zeiss 510 confocal laser scanning system and Axio Imager
microscope using LSM 510 software (release 4.2) (Carl Zeiss
MicroImaging, Inc).
Pulse-chase labeling
Melanocytes grown in a 5cm culture dish until 90–100%
confluency were starved in DMEM without methionine (Cellgro)
supplemented with 10% fetal bovine serum (Sigma-Aldrich),
penicillin (100 units/ml) (Sigma) for 2 hours. Each plate of cells
was labeled with 50 uCi [
35S] methionine (EXPRE35S35S protein
labeling mix; New England Nuclear) for 10 min, washed twice,
and chased in normal growth medium for different periods of time.
Cells were harvested, washed twice with ice-cold PBS, and lysed in
lysis buffer (PBS with 0.1% triton X). The lysates were cleared by
centrifugation at 15,000 g for 10 min at 4uC, and incubated with
mAb TA99 (1:10 dilution, homemade) at 4uC for overnight
followed by rabbit anti-mouse IgG coupled to protein A Sepharose
(1:10 dilution) for 2 hours at 4uC. Immunoprecipitates were
washed with 10 mM Tris/HCl, pH 7.5, 0.15 M NaC1, 5 mM
EDTA, and 1% NP-40 (TNEN), followed by TNEN containing
0.5 M NaCI, and finally with distilled water. For Endo H
digestion, the immunoprecipitates were dissociated by suspending
in 0.2% SDS, heated for 5 min at 100uC, and diluted with 25 ul
0.1 M sodium citrate buffer, pH 5.5, Endo H, 50 mU/ml. The
reaction mixture was layered over with 50ul toluene and digestion
was carried out at 37uC for 18–24 h. Littermate control (+/+,
nur17/+) tubes were treated similarly, except that equal volume of
0.1 M sodium citrate buffer, pH 5.5, was added instead of Endo
H. Proteins were analyzed by 9% SDS-PAGE. Radioactive
protein bands were visualized by fluorography. The proportion
of Tyrp1 without complex N-linked glycans against the total
protein was determined by scanning densitometry using the gel
analysis function of the ImageJ software (http://rsb.info.nih.gov/
ij). The signals at the lower band position were quantified for
Tyrp1 without complex N-linked glycans, and all the signals
spanning the lower and higher band positions were quantified for
the total protein.
Statistical analysis
Student’s t-test was performed for statistical comparison of the
weight of mice, the number of cells positive for Gallyas staining or
the CHOP1 staining between littermate control (+/+, nur17/+)
and nur17 mice and the latency to fall in the rotarod analysis. Two-
way analysis of variance (ANOVA) was performed for the
statistical comparison of the proportion of protein without
complex N-linked glycans in the pulse-chase experiment. Graph-
Pad Prism software (GraphPad software, Inc.) was used for
statistical analysis and to create all graphs reporting numerical
values. * p,0.05, ** p,0.01.
Rotarod analysis
Mice that were of the genotype of +/+ or nur17/+ TG2 (n=5),
nur17/nur17 TG2 (n=5) and nur17/nur17 TG+ (n=5) at 5–8
months of age were subjected to rotarod analysis. Mice were first
exposed to a training period at constant speed to familiarize them
with the rotarod apparatus (Ugo Basile). For the testing, the
rotorod was gradually accelerated (1 rpm/s) from 4 rpm over the
course of 3 min. The time was recorded when a mouse fell from
the device (latency to fall). After all mice fell from the rotorod, the
group was given a rest period and then reloaded on the device.
The testing was performed a total of 3 times for each mouse.
Values from the three trials for each mouse were averaged to give
a single score.
Supporting Information
Figure S1 Genotyping and transgene expression in the trans-
genic mice. (A) Southern blot for the transgene. The mice from
line 2361 and line 2368 with the transgene exhibit two extra bands
(1.06kb and 0.45kb), which are marked by arrowheads. (B)
Northern blot analysis to test the expression of transgene. The
mice from line 2361, control and line 2368 all exhibit the band for
endogenous Arcn1 (4.1kb), while only line 2361 exhibits the band
from the transgene (2.2kb, arrowhead).
Found at: doi:10.1371/journal.pgen.1000956.s001 (2.29 MB TIF)
Figure S2 Immunofluorescence for KDEL in the cerebellum.
Positive staining is observed in both control (left) and nur17 PCs.
Nuclei are stained with DAPI (blue). Scale bar: 10 mm.
Found at: doi:10.1371/journal.pgen.1000956.s002 (1.65 MB TIF)
Figure S3 Comparison of the subcellular localization of
ARCN1. Primary culture of wild-type control (A,C,E) and nur17
(B,D,F) mouse melanocyte are all labeled with anti-ARCN1
(green) indicating the localization of ARCN1 and anti-Golgi
protein (red) (A,B); anti-KDEL (red) (C,D) and anti-bCOP (red)
(E,F). Nuclei are stained with DAPI (blue). Merged pictures are
shown and high magnification pictures are shown in the right
panel. Scale bar for low magnification: 10 mm. Scale bar for high
magnification: 5 mm.
Found at: doi:10.1371/journal.pgen.1000956.s003 (2.18 MB TIF)
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